Sarraf Pasha 4
4 · Cue Biopharma, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Sarraf Pasha
Director
Transactions
- Purchase
Common Stock
2025-12-30$0.31/sh+4,229$1,308→ 4,229 total - Purchase
Common Stock
2025-12-30$0.30/sh+77,148$23,168→ 81,377 total - Purchase
Common Stock
2025-12-30$0.32/sh+86,947$27,597→ 168,324 total - Purchase
Common Stock
2025-12-30$0.31/sh+78,116$24,325→ 246,440 total - Purchase
Common Stock
2025-12-30$0.30/sh+77,417$23,349→ 323,857 total